Abstract
Background Virtual Gene Panels (VGP) comprising disease-associated causal genes are utilized in the diagnosis of rare genetic diseases to evaluate candidate genes identified by whole-genome and whole-exome sequencing. VGPs generated by the PanelApp software were utilized in a UK 100,000 Genome Project pilot study to filter candidate genes, thus enhancing diagnostic efficiency for rare diseases. However, PanelApp also filtered out disease-causing genes in nearly 50% of the cases.
Methods Here, we propose various methods for optimized approach to design VGPs that significantly improve the diagnostic efficiency by leveraging the hierarchical structure of the Mondo disease ontology, without excluding disease-causing genes. We also performed computational experiments on an evaluation dataset comprising 74 patients to determine the optimal VGP design method.
Results Our results demonstrate that the proposed method can significantly enhance rare disease diagnosis efficiency by automatically identifying candidate genes. The proposed method successfully designed VGPs that improve diagnosis efficiency without excluding disease-causing genes.
Conclusion We have developed novel methods for VGP design that leverage the hierarchical structure of the Mondo disease ontology to improve rare genetic disease diagnosis efficiency. This approach identifies candidate genes without excluding disease-causing genes, and thereby improves diagnostic efficiency.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Bioscience Database Center of the Japan Science and Technology Agency, by "Challenging Exploratory Research Projects for the Future" grant from Research Organization of Information and Systems and by JSPS KAKENHI grant number 21K12148 and 23K11886.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Update due to incorrect author name notation
Data Availability
The knowledge graph data used in this study can be freely accessed via the RDF Portal https://rdfportal.org/dataset/pubcasefinder. The data that support the findings of this study were obtained from the Hamamatsu University School of Medicine. Restrictions apply to the availability of this data, which were used under license only for the current study and thus are not publicly available. However, data are available from the authors upon reasonable request and with permission from the Hamamatsu University School of Medicine. The source code has also not yet been released, since it was developed for experimental purposes only.
Abbreviations
- 1UAP
- One class Up for All Paths
- 1UMP
- One class Up for Minimum Paths
- 2UAP
- Two classes up for all paths
- 2UMP
- Two classes up for minimum paths
- Mondo
- Mondo disease ontology
- NGS
- Next-Generation Sequencing
- OR
- Original set
- RDF
- Resource Description Framework
- TH k AP
- All paths up with threshold k
- TH k MP
- Minimum path up with threshold k
- VGP(s)
- Virtual Gene Panel(s)
- WES
- whole exome sequencing
